Insider Trading & Ownership of Pontifax Management 4 G.P. (2015) Ltd.

Location
Herzliya Pituach, Israel
Summary
The estimated value of insider holdings of Pontifax Management 4 G.P. (2015) Ltd. is at least $610,056 dollars as of 17 Oct 2025. Pontifax Management 4 G.P. (2015) Ltd. is the 10%+ Owner of Eloxx Pharmaceuticals, Inc. and owns shares of Eloxx Pharmaceuticals, Inc. stock worth about $443,946. Pontifax Management 4 G.P. (2015) Ltd. is the 10%+ Owner of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $166,110.
Signature
Pontifax Management 4 G.P. (2015) Ltd., By: /s/ Tomer Kariv, Chief Executive Officer
All Insider Reports
All Insider Reports

Notify me when Pontifax Management 4 G.P. (2015) Ltd. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Pontifax Management 4 G.P. (2015) Ltd.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELOX Eloxx Pharmaceuticals, Inc. 10%+ Owner $443,946 13 May 2021
KROS Keros Therapeutics, Inc. 10%+ Owner $166,110 -$84,975,125 -100% 15 Oct 2025
LBRX LB PHARMACEUTICALS INC 10%+ Owner 12 Sep 2025

Insider Transactions Reported by Pontifax Management 4 G.P. (2015) Ltd.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.